Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T22:21:25.932Z.
Calculation as of: 2026-10-06T22:21:25.932Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a08bb0e768e445b647833b1fa03ab76594e1458f06569fc43a1aa259a4caca38
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2024-08-14.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
N/A
EV/FCF RATIO AVG 3Y
N/A
EV/FCF RATIO AVG 5Y
N/A
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Contineum Therapeutics, Inc.
Market Cap
$475.91M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$472.23M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$471.57M
EV/FCF Ratio
N/A
TTM Avg
997.52x
3Y Avg
857.93x
5Y Avg
857.93x
Market Cap
$483.54M
EV/FCF Ratio
11.00x
TTM Avg
7.76x
3Y Avg
12.39x
5Y Avg
16.55x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | $475.91M | N/A | N/A | N/A | N/A |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.23M | N/A | N/A | N/A | N/A |
| Arvinas, Inc. (ARVN)vs › | $471.65M | N/A | 5.27x | 5.30x | 11.22x |
| Cerus Corporation (CERS)vs › | $471.57M | N/A | 997.52x | 857.93x | 857.93x |
| Alpha Teknova, Inc. (TKNO)vs › | $469.12M | N/A | N/A | N/A | N/A |
| Puma Biotechnology, Inc. (PBYI)vs › | $483.54M | 11.00x | 7.76x | 12.39x | 16.55x |
| Kamada Ltd. (KMDA)vs › | $467.90M | 17.00x | 21.93x | 76.52x | 57.94x |
| Evolus, Inc. (EOLS)vs › | $486.01M | N/A | N/A | N/A | N/A |
| Sight Sciences, Inc. (SGHT)vs › | $465.75M | N/A | N/A | N/A | N/A |
| Oculis Holding AG (OCS)vs › | $498.52M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2024-08-14 | 38.58x |
| 2024-08-13 | 36.96x |
| 2024-08-12 | 38.64x |
| 2024-08-09 | 37.03x |
| 2024-08-08 | 37.51x |
| 2024-08-07 | 37.91x |
| 2024-08-06 | 39.97x |
| 2024-08-05 | 37.95x |
| 2024-08-02 | 40.94x |
| 2024-08-01 | 42.12x |
| 2024-07-31 | 43.02x |
| 2024-07-30 | 44.82x |
| 2024-07-29 | 44.82x |
| 2024-07-26 | 44.52x |
| 2024-07-25 | 44.60x |
| 2024-07-24 | 44.65x |
| 2024-07-23 | 45.30x |
| 2024-07-22 | 45.14x |
| 2024-07-19 | 43.16x |
| 2024-07-18 | 44.57x |
| 2024-07-17 | 44.61x |
| 2024-07-16 | 45.71x |
| 2024-07-15 | 44.52x |
| 2024-07-12 | 44.15x |
| 2024-07-11 | 44.52x |
| 2024-07-10 | 44.61x |
| 2024-07-09 | 43.93x |
| 2024-07-08 | 44.34x |
| 2024-07-05 | 42.97x |
| 2024-07-03 | 43.06x |
| 2024-07-02 | 44.02x |
| 2024-07-01 | 44.52x |
| 2024-06-28 | 39.10x |
| 2024-06-27 | 40.92x |
| 2024-06-26 | 44.20x |
| 2024-06-25 | 42.81x |
| 2024-06-24 | 41.63x |
| 2024-06-21 | 40.67x |
| 2024-06-20 | 42.41x |
| 2024-06-18 | 41.40x |
| 2024-06-17 | 36.53x |
| 2024-06-14 | 36.53x |
| 2024-06-13 | 37.48x |
| 2024-06-12 | 37.59x |
| 2024-06-11 | 36.45x |
| 2024-06-10 | 39.60x |
| 2024-06-07 | 37.03x |
| 2024-06-06 | 36.72x |
| 2024-06-05 | 36.68x |
| 2024-06-04 | 36.10x |
| 2024-06-03 | 36.10x |
| 2024-05-31 | 35.45x |
| 2024-05-30 | 34.94x |
| 2024-05-29 | 35.50x |
| 2024-05-28 | 34.46x |
| 2024-05-24 | 36.15x |
| 2024-05-23 | 36.71x |
| 2024-05-22 | 36.31x |
| 2024-05-21 | 36.53x |
| 2024-05-20 | 36.07x |
| 2024-05-17 | 35.73x |
| 2024-05-16 | 29.24x |
| 2024-05-15 | 29.70x |
| 2024-05-14 | 29.90x |
| 2024-05-13 | 29.93x |
| 2024-05-10 | 30.37x |
| 2024-05-09 | 30.64x |
| 2024-05-08 | 30.21x |
| 2024-05-07 | 29.04x |
| 2024-05-06 | 29.05x |
| 2024-05-03 | 28.08x |
| 2024-05-02 | 29.16x |
| 2024-05-01 | 29.89x |
| 2024-04-30 | 30.09x |
| 2024-04-29 | 30.62x |
| 2024-04-26 | 30.25x |
| 2024-04-25 | 30.61x |
| 2024-04-24 | 30.53x |
| 2024-04-23 | 30.50x |
| 2024-04-22 | 30.27x |
| 2024-04-19 | 29.85x |
| 2024-04-18 | 29.93x |
| 2024-04-17 | 29.81x |
| 2024-04-16 | 30.02x |
| 2024-04-15 | 28.77x |
| 2024-04-12 | 29.95x |
| 2024-04-11 | 30.51x |
| 2024-04-10 | 28.96x |
| 2024-04-09 | 29.57x |
| 2024-04-08 | 29.62x |
| 2024-04-05 | 29.82x |
